Association of a functional RAD52 genetic variant locating in a miRNA binding site with risk of HBV-related hepatocellular carcinoma

Molecular Carcinogenesis

Volumn 54, Issue 9, 2015, Pages 853-858

  Li, Ziqiang ^a   Guo, Yuan ^a   Zhou, Liqing ^b   Ge, Yunxia ^c   Wei, Lili ^d   Li, Lichao ^c   Zhou, Changchun ^d   Wei, Jinyu ^c   Yuan, Qipeng ^c   Li, Jie ^a   Yang, Ming ^c  

^a SHANDONG UNIVERSITY   (China)

^b Huaian No 2 Hospital   (China)

^c BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

^d SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Chinese; Genetic polymorphism; HBV; HCC; RAD52; Susceptibility

Indexed keywords

MESSENGER RNA; MICRORNA; PROTEIN LET 7; RAD52 PROTEIN; UNCLASSIFIED DRUG; RAD52 PROTEIN, HUMAN;

ADULT; ARTICLE; BINDING SITE; CANCER RISK; CANCER SUSCEPTIBILITY; CHINA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOMIC INSTABILITY; GENOTYPE PHENOTYPE CORRELATION; HAN CHINESE; HEPATITIS B VIRUS; HETEROZYGOTE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SINGLE NUCLEOTIDE POLYMORPHISM; CARCINOMA, HEPATOCELLULAR; CHEMISTRY; COMPLICATION; GENETICS; HEPATITIS B; ISOLATION AND PURIFICATION; LIVER; LIVER NEOPLASMS; METABOLISM; MIDDLE AGED; VIROLOGY;

HEPATITIS B VIRUS;

BINDING SITES; CARCINOMA, HEPATOCELLULAR; CHINA; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RAD52 DNA REPAIR AND RECOMBINATION PROTEIN;

EID: 84938970942     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22156     Document Type: Article

References (39)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108.
2. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132:2557-2576.
3. Zhong R, Liu L, Tian Y, et al. Genetic variant in SWI/SNF complexes influences hepatocellular carcinoma risk: A new clue for the contribution of chromatin remodeling in carcinogenesis. Sci Rep 2014; 4:4147.
4. Zhong R, Tian Y, Liu L, et al. HBV-related hepatocellular carcinoma susceptibility gene KIF1B is not associated with development of chronic hepatitis B. PLoS ONE 2012; 7:e28839.
5. Jiang DK, Sun J, Cao G, et al. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet 2013; 45:72-7275.
6. Li S, Qian J, Yang Y, et al. GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genet 2012; 8:e1002791.
7. Chan KY, Wong CM, Kwan JS, et al. Genome-wide association study of hepatocellular carcinoma in Southern Chinese patients with chronic hepatitis B virus infection. PLoS ONE 2011; 6:e28798.
8. Zhang H, Zhai Y, Hu Z, et al. Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet 2010; 42:755-758.
9. Lok BH, Powell SN. Molecular pathways: Understanding the role of Rad52 in homologous recombination for therapeutic advancement. Clin Cancer Res 2012; 18:6400-6406.
10. Singleton MR, Wentzell LM, Liu Y, West SC, Wigley DB. Structure of the single-strand annealing domain of human RAD52 protein. Proc Natl Acad Sci USA 2002; 99:13492-13497.
11. Jensen RB, Carreira A, Kowalczykowski SC. Purified human BRCA2 stimulates RAD51-mediated recombination. Nature 2010; 467:678-683.
12. Lok BH, Carley AC, Tchang B, Powell SN. RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination. Oncogene 2013; 32:3552-3558.
13. Feng Z, Scott SP, Bussen W, et al. Rad52 inactivation is synthetically lethal with BRCA2 deficiency. Proc Natl Acad Sci USA 2011; 108:686-691.
14. Jiang Y, Qin Z, Hu Z, et al. Genetic variation in a hsa-let-7 binding site in RAD52 is associated with breast cancer susceptibility. Carcinogenesis 2013; 34:689-693.
15. Shi J, Chatterjee N, Rotunno M, et al. Inherited variation at chromosome 12p13.33, including RAD52, influences the risk of squamous cell lung carcinoma. Cancer Discov 2012; 2:131-139.
16. Wang Y, Lu Y, Toh ST, et al. Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3. J Hepatol 2010; 53:57-66.
17. Timofeeva MN, Hung RJ, Rafnar T, et al. Influence of common genetic variation on lung cancer risk: Meta-analysis of 14900 cases and 29485 controls. Hum Mol Genet 2012; 21:4980-4995.
18. Siraj AK, Al-Rasheed M, Ibrahim M, et al. RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population. J Endocrinol Invest 2008; 31:893-899.
19. Danoy P, Michiels S, Dessen P, et al. Variants in DNA double-strand break repair and DNA damage-response genes and susceptibility to lung and head and neck cancers. Int J Cancer 2008; 123:457-463.
20. Beesley J, Jordan SJ, Spurdle AB, et al. Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: Results from two Australian studies and an additional validation set. Cancer Epidemiol Biomarkers Prev 2007; 16:2557-2565.
21. Kuschel B, Auranen A, McBride S, et al. Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 2002; 11:1399-1407.
22. Liu L, Zhou C, Zhou L, et al. Functional FEN1 genetic variants contribute to risk of hepatocellular carcinoma, esophageal cancer, gastric cancer and colorectal cancer. Carcinogenesis 2012; 33:119-123.
23. Shi TY, Yang G, Tu XY, et al. RAD52 variants predict platinum resistance and prognosis of cervical cancer. PLoS ONE 2012; 7:e50461.
24. Yang M, Guo H, Wu C, et al. Functional FEN1 polymorphisms are associated with DNA damage levels and lung cancer risk. Hum Mutat 2009; 30:1320-1328.
25. Zhang X, Wei J, Zhou L, et al. A functional BRCA1 coding sequence genetic variant contributes to risk of esophageal squamous cell carcinoma. Carcinogenesis 2013; 34:2309-2313.
26. Lehmann U, Kreipe H. Real-time PCR analysis of DNA and RNA extracted from formalin-fixed and paraffin-embedded biopsies. Methods 2001; 25:409-418.
27. Crosby ME, Kulshreshtha R, Ivan M, Glazer PM. MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res 2009; 69:1221-1229.
28. Osada H, Takahashi T. let-7 and miR-17-92: Small-sized major players in lung cancer development. Cancer Sci 2011; 102:9-17.
29. Boyerinas B, Park SM, Hau A, Murmann AE, Peter ME. The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer 2010; 17:F19-36.
30. Mezzanzanica D, Bagnoli M, De Cecco L, Valeri B, Canevari S. Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications. Int J Biochem Cell Biol 2010; 42:1262-1272.
31. Peter ME. Let-7 and miR-200 microRNAs: Guardians against pluripotency and cancer progression. Cell Cycle 2009; 8:843-852.
32. Zhou L, Zhang X, Li Z, et al. Association of a genetic variation in a miR-191 binding site in MDM4 with risk of esophageal squamous cell carcinoma. PLoS ONE 2013; 8:e64331.
33. Liu J, Tang X, Li M, et al. Functional MDM4 rs4245739 genetic variant, alone and in combination with P53 Arg72Pro polymorphism, contributes to breast cancer susceptibility. Breast Cancer Res Treat 2013; 140:151-157.
34. Yao J, Liu L, Yang M. Interleukin-23 receptor genetic variants contribute to susceptibility of multiple cancers. Gene 2014; 533:21-25.
35. Zheng J, Deng J, Xiao M, et al. A sequence polymorphism in miR-608 predicts recurrence after radiotherapy for nasopharyngeal carcinoma. Cancer Res 2013; 73:5151-5162.
36. Wu H, Zheng J, Deng J, et al. A genetic polymorphism in lincRNA-uc003opf.1 is associated with susceptibility to esophageal squamous cell carcinoma in Chinese populations. Carcinogenesis 2013; 34:2908-2917.
37. Zheng J, Jiang L, Zhang L, et al. Functional genetic variations in the IL-23 receptor gene are associated with risk of breast, lung and nasopharyngeal cancer in Chinese populations. Carcinogenesis 2012; 33:2409-2416.
38. Gao Y, He Y, Ding J, et al. An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3′ untranslated region confers risk for hepatocellular carcinoma. Carcinogenesis 2009; 30:2064-2069.
39. Zheng J, Liu B, Zhang L, et al. The protective role of polymorphism MKK 4-1304 T>G in nasopharyngeal carcinoma is modulated by Epstein-Barr virus' infection status. Int J Cancer 2012; 130:1981-1990.